Browse studies

Find your next paid study

27,300 recruiting studies available now

Identification of Critical Thermal Environments for Aged Adults

This study evaluates critical environmental limits (temperature and humidity) above which older adults are unable to effectively thermoregulate. Participants w…

Aging

Estimated

~$500 – $7,500

Actual pay is set by the research site.

Penn State UniversityNCT04284397

Phase 2

ELDORADO: a Randomized Phase II Trial of Elranatamab or Daratumumab in Combination With Lenalidomide, Bortezomib, and Dexamethasone (RVd Lite) in Newly Diagnosed, Transplant Ineligible/Deferred Multiple Myeloma

This research study is being done to compare the efficacy and safety of the combination of elranatamab, lenalidomide, bortezomib, dexamethasone versus the comb…

Multiple MyelomaNewly Diagnosed Multiple MyelomaTransplant Ineligible+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Massachusetts General HospitalNCT07247097

Observational

Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention for Under-served Hispanics

The proposed study will develop and test an implementation strategy called Salud en Mis Manos-Dissemination and Implementation Assistance (SEMM-DIA) which is a…

Cancer Prevention

Estimated

~$10 – $750

Actual pay is set by the research site.

The University of Texas Health Science Center, HoustonNCT05524480

Phase 3

Multimodal Analgesia Pathway Assessing Role of Suzetrigine for the Reduction of Opioid Use Following Ureteroscopic Surgery

Urologic surgery has advanced with new technologies to allow less invasive management of common afflictions such as kidney stones, these procedures are notorio…

Opioid Consumption, PostoperativeMultimodal AnalgesiaUreteroscopy+2 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Brigham and Women's HospitalNCT07654296

Phase 3

Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer

This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cance…

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Children's Oncology GroupNCT06513962

Phase 1

A Phase 1/2, Multicenter, Open-Label, Dose-Escalation, Safety, Tolerability, and Clinical Activity Study of a Single Dose of JAG201 Gene Therapy Delivered Via Intracerebroventricular Administration in Participants With SHANK3 Haploinsufficiency

This is a Phase 1/2, first in human, open-label, dose-escalation study to evaluate the safety, tolerability, and clinical activity of a single dose of JAG201 a…

SHANK3 HaploinsufficiencyPhelan-McDermid Syndrome

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Jaguar Gene Therapy, LLCNCT06662188

Observational

Stimulating the Aging Brain: Noninvasive Brain and Sensory Stimulation Strategies in Aging

The goal of this project is to investigate whether transcranial electrical stimulation and sensory stimulation affect language outcomes in individuals with pri…

Primary Progressive Aphasia

Estimated

~$10 – $750

Actual pay is set by the research site.

Medical College of WisconsinNCT07650188

Clinical and Radiographic Outcomes of Patients Treated With Mg OSTEOCRETE

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-rela…

Cancer of BoneTraumaAseptic Loosening of Orthopaedic Hardware

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Santiago Lozano-CalderonNCT06720142

Observational

Non-invasive Central Venous Pressure Estimation in Pediatric Patients

Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric p…

Central Venous Pressure

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Compremium AGNCT06885073

Phase 2

Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum

To look at the effectiveness of sacituzumab tirumotecan (MK-2870) in treating participants with treatment-refractory unresectable and/or metastatic anal/rectal…

Phase 2Sacituzumab TirumotecanRefractory Metastatic+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07511023

Observational

Functional Radiosurgery for Easing or Eliminating Debilitating Oncologic Morbidity (FREEDOM)

The investigators propose to conduct a study in medically refractory cancer pain patients utilizing radiosurgery to ablate the pituitary hypophysis, as well as…

Cancer Pain

Estimated

~$10 – $750

Actual pay is set by the research site.

Jonsson Comprehensive Cancer CenterNCT07605546

Phase 2

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KPd) in Patients With Relapsed Multiple Myeloma

Doctors leading this study hope to learn if the combination of belantamab mafodotin, carfilzomib, pomalidomide, and dexamethasone is effective and safe when gi…

Multiple MyelomaRelapse Multiple Myeloma

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of ChicagoNCT05789303